Axona
  • Patient information website
Axona® questions? Call us at 1-877-649-0004.
  • Search
  • Home
  • DCGM
    • Normal cerebral glucose metabolism
    • DCGM in Alzheimer's disease
  • Ketone bodies
    • Ketone bodies background
    • Ketone bodies in Alzheimer’s disease
  • About Axona
    • Axona MOA
    • Efficacy
    • Safety
    • Clinical trials
    • Administering Axona
    • Alzheimer’s disease management
    • Pharmacy information
  • Case studies
    • Rosemary
    • Geraldine
  • FAQs
  • Resources

Home > Site map

Site map

  • Home
  • DCGM
    • Normal cerebral glucose metabolism
    • DCGM in Alzheimer's disease
  • Ketone bodies
    • Ketone bodies background
    • Ketone bodies in Alzheimer’s disease
  • About Axona
    • Axona MOA
    • Efficacy
    • Safety
    • Clinical trials
    • Administering Axona
    • Alzheimer’s disease management
    • Pharmacy information
  • Case studies
    • Rosemary
    • Geraldine
  • FAQs
  • Contact us
  • Resources
  • References
  • Company information
  • Axona package insert
  • Privacy Policy
  • Support
  • Legal Disclaimer
 

Axona is a medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease.

Axona should be used with caution in patients who are at risk for ketoacidosis, for example, patients with a history of alcohol abuse and poorly controlled diabetics; or those who have a history of inflammation of the gastrointestinal system, metabolic syndrome, and/or renal dysfunction. Axona contains caseinate and whey (dairy), and lecithin (soy). Contains: milk and soy.

Please see product information.

This website contains information relating to Alzheimer's disease and other specific medical conditions and their therapies. Such information is provided for educational purposes only, does not constitute medical advice, and is not meant to be a substitute for the advice of a doctor or other healthcare professional. You should not use this information for diagnosing a health problem or disease. In order for you to make informed healthcare decisions, you should always consult with a doctor or healthcare professional for your, or your loved one's, personal medical needs.

This site is intended for residents of the United States only. Axona is available in the United States only. The licensed material on this website is being used for illustrative purposes only; and any person depicted in the licensed material, if any, is a model.

Cerecin (formerly known as Accera), Axona, and the Axona logo are trademarks or registered trademarks of Cerecin, Inc.
Patents issued: USP 6,835,750, EP 1292294, JP 3486778, and USP 8,426,468; and patents pending.
© 2020 Cerecin, Inc.   All rights reserved.  AC-20-880  07/20

  • Home
  • Diminished cerebral glucose metabolism
  • How ketone bodies can help in AD
  • About Axona
  • Dosage and administration
  • Company
  • Case studies
  • Resources
  • References
  • FAQs
  • Contact us
  • Patient site
  • Product Information
  • Privacy Policy
  • Site map
  • Overview
    • Normal cerebral glucose metabolism
    • DCGM in Alzheimer's disease
  • Overview
    • Ketone bodies background
    • Ketone bodies in Alzheimer’s disease

See how ketone bodies can work together with glucose to fuel the brain in Alzheimer’s disease
Click here >

  • Overview
    • Axona MOA
    • Efficacy
    • Safety
    • Clinical trials
    • Administering Axona
    • Alzheimer’s disease management
    • Pharmacy information
cash casino deposit new no online required casino deposit no required captain jack casino no deposit 1 minimum deposit casinos no deposit casinos rtg casino code deposit no online rtg william hill casino 10 no deposit